Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...

U.S. antitrust enforcers should consider blocking a bid by Compass, the nation’s largest residential real estate broker, to acquire rival Anywhere Real Estate, amid a housing shortage, two Democratic ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...

Revenue: INR 572 crores for the quarter, a 6% increase compared to the corresponding quarter last year. Sales to Third-Party: INR 490 crores with a realization price of 12.5. Blends Revenue: INR 271 ...

Compass, the nation’s largest residential real-estate brokerage, has a pitch for home buyers: Sign with us, and you’ll see homes nobody else can. The company maintains a growing inventory of “Private ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. A psychedelic medicine for hard-to-treat depression ...

The American Depositary Shares ("ADS") of the United Kingdom-based biotech Compass Pathways plc (CMPS) are soaring today, after management announced its psychedelic drug candidate COMP006 had met the ...

Compass, Inc. (NYSE:COMP) is one of the 12 Best Stocks Under $10 to Invest In Right Now. On February 9, UBS raised its price target on Compass, Inc. (NYSE:COMP) from $12 to $17 and maintained its Buy ...

Rogers Healy and Associates, a Dallas area independent brokerage, has merged with Compass. Founder Rogers Healy said he will reduce day-to-day involvement and devote more time to venture capital ...

Camlin Fine Sciences Limited is an integrated manufacturer specializing in traditional antioxidants primarily used for extending shelf life, with its operations encompassing four main areas: shelf ...

Following a major update for the 2023 model year, the Jeep Compass carries over with minor changes for 2024. Jeep's in-betweener sits above the subcompact Renegade and below the Grand Cherokee within ...